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Gene products coded for by the major hisocompatibility complex (MHC) can 
serve as target antigens for cytotoxic T lymphocytes (CTL) (1). A variety of test 
systems are available which have yielded information consistently reinforcing 
the importance of this complex of genes in the generation and effector phases of 
the cytotoxic immune response.  Originally, it was shown that allogeneically- 
induced CTL had specificity primarily for the products of the K and D loci of  the 
mouse H-2 complex (2). More recently this has also been found to be the case for 
xenogeneic immunizations (3, 4).  Additional examples of T cell-mediated lysis 
have been reported involving viral-infected or chemically-modified syngeneic 
stimulating and target cells in which homology at H-2K or H-2D was required 
between the responding and target cells for appreciable  lysis to occur  (5-7). 
Moreover, CTL specific for minor histecompatibility antigens are able to lyse 
only target cells bearing these membrane antigens and sharing a common  H-2K 
or H-2D gene product with the effector (8, 9). 
Two hypotheses have been  proposed to explain the  requirement for H-2  identity 
between effector and targets in these systems. CTL may recognize new antigenic determi- 
nants created by the interaction of the modifier with syngeneic K and D gene products. 
Alternately, a dual recognition system may exist, requiring an antigen-specific receptor 
as well as a second receptor with specificity for homologous H-2K or H-2D determinants 
(5). Neither model can be excluded at this time. 
The I  region  also  contains genes  coding for histocompatibility  loci since  animals 
differing at the/-A or I-C regions of the H-2 complex reject skin grafts (10-12), though 
less rapidly than mice differing at the H-2K or H-2D regions. Also CTL can be generated 
to I region determinants but less efficiently than CTL specific for H-2K or H-2D gene 
products  (12-14). The question can therefore  be  raised,  whether the I  region  minor 
histocompatibility  loci function independently from the H-2K or H-2D loci or whether I 
region-specific cytolysis requires the participation of  H-2K or H-2D gene products of the 
target cell. 
This communication  illustrates the generation of  CTL showing specificity for I 
region determinants in primary mixed lymphocyte cultures. Further, we dem- 
onstrate by genetic analysis and by the use of specific alloantisera that CTL 
directed to Ia determinants (a) do not see these antigens as modifications of/-/- 
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TABLE  I 
Generation of I Region-Specific Primary Cytolytic Responses by A .TH 
Spleen Cells In Vitro 
Experiment  Stimulator  Target*  Relevant$ target  Specific release of 
specificities  S~Cr 
% 
1  A.TL  A.TL  I  55.3 
A.TL  B10.S  None  0.3 
2  A.TL  A.TL  I  60.5 
B10.BR  B10.BR  K,1,D  92.0 
* Effector to target ratio  was 100:1. Spontaneous release for LPS blasts was 30-38% for A.TL,  37% for 
B10.BR,  and 30% for B10.S. 
$ H-2-related specificities which differ for responder and stimulator, but which are shared by stimulator 
and target, excluding  those products of the S region. 
2K or H-2D gene products but as independent gene products coded for by the I 
region, and (b)  they do not require interaction with target cells bearing the 
same H-2K or H-2D gene product as the effector CTL. 
Materials and Methods 
Mice.  6- to 12-wk-old male and female mice from our own breeding colony or purchased from 
The Jackson Laboratory, Bar Harbor, Maine were used in these studies. Some A.TL mice were the 
gift of Dr. David Sachs, National Cancer Institute. 
Antisera.  Alloantisera were raised by six to eight intraperitoneal injections of lymphoid cells. 
Donor-recipient combinations used and the specificity of each serum are given in the legend to 
Table III. 
Generation of  Effector Cells and the 51Cr-Release Assay.  The method used to generate cytotoxic 
effector cells to allogeneic targets has been described elsewhere (15).  The ~lCr-release assay used 
in this study and the method of antisera inhibition have been previously elucidated in detail (16). 
Lipopolysaccharide-induced (LPS) blast spleen cells used as targets in the 51Cr-release assay were 
produced by incubating 4  ×  106 spleen cells with 10 /~g of LPS in 2 ml of medium consisting of 
RPMI 1640 supplemented with 10% heat inactivated fetal calf serum and glutamine.  LPS blasts 
produced in this fashion were shown to contain approximately 80% Ia-positive cells by complement 
mediated cytotoxicity (Unpublished results). 
Percent-specific release was calculated as: 
E-C 
--  ×  100%  (16) 
FT-C 
Results 
Generation of I  Region-Specific CTL.  Several investigators have reported 
significant cytolysis generated by responder/stimulator pairs differing at the I 
region of the H-2 complex (12-14). Results shown in Table I confirm this finding. 
A.TH  responder cells  stimulated by irradiated A.TL  spleen  cells  lyse LPS 
induced blast A.TL targets. No significant cytotoxicity could be demonstrated 
against control B10.S LPS induced blast targets. Significant/region killing was 
always observed and the lytic activity ranged between 12 and 60% in different 
experiments. 
As shown in  Table  I  and  Fig.  1,  CTL-specific  responses to I  region gene 
products are weaker than those primarily directed to the K and D gene products 
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FIG. i.  Lysis of  targets  bearing  relevant  K,  I,  and  D or  I  region determinants  by allogenei- 
cally  induced CTL, A.TH anti-B10.BR effectors  were assayed on B10.BR (closed  circles)  or 
A.TL (open circles)  targets.  Spontaneous release  for  LPS-blast targets  was 37% for  B10.BR 
and 30% for  A.TL. 
which differ for the entire H-2  complex, kill B10.BR targets more effectively 
than do A.TH anti-A.TL induced killers, which differ only at the I re,on, when 
compared at the same effect/target (E/T) ratios.  When A.TH responders are 
stimulated by B10.BR  spleen cells and lysis on B10.BR  and A.TL targets is 
compared (Fig. 1), it can be seen that most of the lytic activity generated by this 
combination appears to be directed to K  and D  gene products rather than to I 
region products. From Fig. 1, it can be seen that CTL which react primarily with 
I  region determinants (i.e., lyse A.TL targets) comprise fewer than 10% of the 
allogeneic effector cells. 
I Region-Specific CTL Lyse Targets Which Differ at H-2K and~or H-2D From 
the Stimulator.  CTL might recognize Ia antigens as independent cell surface 
antigens or in relationship with K  and D coded molecules. Table II shows two 
experiments in which A.TH responders were stimulated by spleen cells which 
differed at the I region. The A.TH and anti-A.TL effector cells were then tested 
on B10.A targets which shared the I and D regions or B10.BR targets which only 
share the I region with the stimulator cells. A.TH anti-A.TL CTL lyse B10.BR 
and B10.A targets well and the magnitude of this lysis is comparable to that 
seen  by  A.TH  anti-A.TL  CTL  on  A.TL  targets.  Furthermore,  as  indicated 
previously, CTL generated in A.TH  anti-B10.BR cultures lyse A.TL targets. 
Thus, I  region-specific CTL can be efficiently assayed on targets which differ 1390  BILLINGS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
I Region-Specific Primary Cytolytic Responses by A.TH Spleen Cells 
on H-2K and D Incompatible Targets 
Experiment  Stimulator  Target*  Shared~ specifici-  Specific release of 
ties  S~Cr 
% 
I  A.TL  A.TL  K,I,D  60.5 
A.TL  B10.A  I,D  57.5 
A.TL  B10.BR  I  54.5 
B10.BR  A.TL  I  42.5 
2  A.TL  B10.A  I,D  17.0 
A.TL  B10.BR  I  26.2 
B10.BR  A.TL  I  22.1 
* Effeetor to target ratio was 100:1. Spontaneous release of LPS blasts was 30-33%  for A.TL, 22-36%  for 
B10.A, and 33-37%  for B10.BR. 
H-2-related  specificities shared by stimulator and target, excluding those products  of the S  region. 
genetically from the stimulating strain at the K and/or D loci, i.e., the I region 
antigens appear to be seen as independent cell surface determinants. 
Specific  Inhibition  of I  Region  Cytolysis  by Anti-Ia Antiserum.  We next 
attempted to show that CTL generated to I  region differences could be specifi- 
cally blocked by anti-Ia antiserum directed to specificities present on the target. 
Cytolysis of targets by CTL generated in A.TH anti-A.TL cultures was signifi- 
cantly inhibited by addition of anti-Ia  k antiserum (Table III). 
To confirm the observation that Ia antigens act as independent target anti- 
gens for CTL,  we attempted to inhibit I  directed killing with an anti-H-2D  d 
antiserum when both responder and stimulator and responder and target shared 
the H-2D  d allele. Thus, A.TH anti-A.TL cultures were assayed on B10.A tar- 
gets. If I  region determinants acted as modifiers of H-2D gene products then 
anti-Ia  k antiserum and anti-H-2D  d antiserum should inhibit CTL because stim- 
ulator and target bear the same I and D alleles. Likewise, if H-2D homology 
between responder and target was required to demonstrate I  region specific 
CTL,  both antisera should significantly inhibit cytolysis. As can be  seen in 
Table  III,  experiment 2,  the  anti-Ia  k antiserum inhibited cytolysis to  a  far 
greater extent than the anti-H-2D  d. The same anti-H-2D  d antiserum very effec- 
tively inhibited the lysis produced by CTL generated in allogeneic combinations 
by using B10 responders and BALB/c stimulators when assayed on these B10.A 
targets. 
Discussion and Summary 
CTL specific for determinants coded for by the I  region of the H-2 complex 
can be generated in vitro by sensitization with cells carrying allogeneic  I region 
determinants. The detection of/region specific CTL is dependent upon testing 
target  cells which express  sufficient levels  of these  determinants,  thus  we 
employed LPS blasts  as target cells.  When analyzing allogeneically induced 
CTL,  the clones reactive with K  and D  region products greatly exceed those 
generated to Ia antigens. It has been demonstrated by genetic analysis and by 
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TABLE  HI 
Inhibition of I Region Primary Cytolytic Responses  by Anti.Ia Antisera* 
1391 
Experi-  Response  Stimulator  Targets  Shared specifici- 
ment  ties§ 
Antiserumll 
Control  aIa  k  aH-2D  d 
1  A.TH  A.TL  A.TL  KJ~  60.5  34.5  61.0 
A.TH  A.TL  BI0.A  I,D  57.5  37.5  65.2 
2  A.TH  A.TL  B10.A  I,D  17.0  3.8  16.5 
B10  BALB/c  B10.A  D  37.2  24,0  13.7 
* Values represent percent-specific  release of S~Cr. 
S Effector to target ratio of 100:1. Sp~mtaneous release of LPS blasts was 30% for A.TL and 22-36%  for B10.A. 
§ Ho2.relatsd specificities shared by stimulator and target excluding the products of the S  region. 
II Control  consisted of SMEM-10;  (16) anti-la  k antiserum is A.TH anti-A.TL with a  lytic titer of 1/1280,  anti-H-2D d is (B10  x 
LP.RIII)F1 anti-18 R with a lytic titer of >1/640.  Both antisera were used at a final dilution of 1:12. 
H-2K and H-2D gene products. CTL directed to the I  region determinants lyse 
all targets bearing the appropriate Ia antigens even if the target cells differ at 
H-2K and/or D from the stimulator. An antiserum specific for I region antigens 
significantly inhibits target lysis by CTL, while addition of specific antiserum 
directed to the H-2D d products of  the target has little or no affect on the ability of 
/-specific CTL to lyse appropriate Ia bearing targets. 
Ia antigens co-cap, redistribute, and immunoprecipitate independently of K 
and D molecules (17). It now appears that functionally as well, Ia antigens act 
separately from K and D antigens in their ability to generate specific CTL. Since 
by all biochemical and functional criteria these Ia antigens are not associated 
with K and D coded molecules, they appear to represent the products of a third 
transplantation locus in the mouse MHC as has been suggested by the graft 
rejection studies of Klein et al.  (10, 12). 
In light of the findings of Bevan (8) and Gordon, et al.  (9), that CTL stimu- 
lated by antigens coded for by minor histocompatibility loci or the H-Y locus 
require presentation of these antigens on targets syngeneic at H-2K or D to the 
responders, I region determinants clearly do not act as other minor histocompat- 
ibility loci in this respect. 
The H-2  complex thus codes for at least three molecules which can act as 
independent CTL stimulating antigens. Viruses, tumor-specific transplanta- 
tion antigens, chemicals, and minor H antigens appear to behave as modifiers 
of H-2K and D  determinants, making them recognizable to syngeneic CTL. 
Studies are now in progress to test whether syngeneic  I  region determinants 
can also be  chemically altered and stimulate CTL  in  systems which have 
shown such modifications and activities for K  and D  molecules. 
Whether there exists a special regulatory role for the relatively few I  region 
reacting clones remains unclear. Within the I region, there are genes which 
regulate many immune responses. The existence of a small number of clones of 
lymphocytes with  receptors  which are  committed to  recognizing I  region 
products independently of H-2K and D  products, is suggestive of a  possible 
regulatory role for these cells. 
Note/tdcIed in Proof.  Klein et al. 1977. (J. Exp. Med. 145: 450.) have reported similar 
findings based on genetic evidence since submission of this manuscript. 1392  BILLINGS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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